1. Adiga, Divya, Bhat, Samatha, Chakrabarty, Sanjiban, Kabekkodu, Shama Prasada. 2022. DOC2B is a negative regulator of Wnt/β-catenin signaling pathway in cervical cancer. In Pharmacological research, 180, 106239. doi:10.1016/j.phrs.2022.106239. https://pubmed.ncbi.nlm.nih.gov/35500882/
2. Zhang, Jing, Oh, Eunjin, Merz, Karla E, Tunduguru, Ragadeepthi, Thurmond, Debbie C. 2019. DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle. In Diabetologia, 62, 845-859. doi:10.1007/s00125-019-4824-2. https://pubmed.ncbi.nlm.nih.gov/30707251/
3. Houy, Sébastien, Groffen, Alexander J, Ziomkiewicz, Iwona, Pinheiro, Paulo S, Sørensen, Jakob Balslev. 2017. Doc2B acts as a calcium sensor for vesicle priming requiring synaptotagmin-1, Munc13-2 and SNAREs. In eLife, 6, . doi:10.7554/eLife.27000. https://pubmed.ncbi.nlm.nih.gov/29274147/
4. Kabekkodu, Shama Prasada, Bhat, Samatha, Radhakrishnan, Raghu, Mundyat, Gopinath Puthiya, Satyamoorthy, Kapaettu. 2014. DNA promoter methylation-dependent transcription of the double C2-like domain β (DOC2B) gene regulates tumor growth in human cervical cancer. In The Journal of biological chemistry, 289, 10637-10649. doi:10.1074/jbc.M113.491506. https://pubmed.ncbi.nlm.nih.gov/24570007/